Tag Archives: AKAM

oil stock

Donald Trump’s win has done something extraordinary to the financial sector. Just look at this one-month chart for the Financial Select Sector SPDR ETF (XLF):

Banks Love Trump

This is unexpected on two levels.

First, of course, Trump’s very election came as a shock to many. Second, there was no shortage of people saying stocks would tank if the real estate mogul....More>>>

Top 10 Gold Stocks For 2017

The Earnings Surprise Isn’t That Exciting

McDonald’s investors (NYSE:MCD) are celebrating a Trump victory that will usher in an administration far more friendly to businesses. A Republican government may do its part in avoiding things like the golden arch being liable for independent contractor violations or in voiding the penalties faced by employers under the Obamacare mandates.....More>>>

Top 5 Clean Energy Stocks To Own Right Now

During the recession, it was much easier to find mega-conglomerates that fit our purchase criteria, but the upward march of stocks has significantly pared back the list of such candidates, notes Benj Gallander, editor of Contra the Heard.

General Electric (GE) — our Top Pick for conservative investors in 2017 — continues to play musical chairs, buying and selling subsidiaries....More>>>

shares of stock

William Patalon III

Since the moment it was announced, we’ve been highly bullish on the complicated-but-intriguing deal that would combine the oilfield services unit of General Electric Co. (NYSE: GE) and all of sector rival Baker Hughes Inc. (NYSE: BHI).

But investors seem confused by the deal – about whether it was a shrewd move or a panic play by GE.

I understand....More>>>

Top Medical Stocks To Invest In Right Now

Are you an investor interested in learning more about Vitality Biopharma Inc (OTCMKTS:VBIO)? Or, are you looking to take your first look at VBIO? A SeeThruEquity research report posted in August not only has you covered, it underscores all of its hidden bullishness. The report also explains a very impressive target price for Vitality Biopharma shares. In short, the research outfit now believes the....More>>>